Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$1.13
NASDAQLPCN
Open
$1.15
Change
-$0.04 (-3.42%)
Day's Range
$1.10 - $1.16
52-Week Range
$0.98 - $2.42
Volume
329.2K
Market Cap
$99.8M